Summary: Researchers made a groundbreaking discovery in the study of Long COVID, identifying that the integrity of blood vessels in the brain is compromised in patients experiencing brain fog and cognitive decline. The study utilized a novel MRI technique to reveal “leakiness” in the brain’s blood vessels, providing an objective method to distinguish patients with […]
Scientists are investigating whether an oral drug sprinkled with gold nanoparticles could one day treat neurodegenerative diseases like Parkinson’s and multiple sclerosis. The experimental medicine, called CNM-Au8, has now shown success in boosting the brain’s metabolism in phase II clinical trials. Research on the safety and efficacy of the daily drug is still ongoing, but […]
Oxytocin, a hormone renowned for fostering emotional bonds and psychological well-being in animals, also plays a pivotal role in cognitive functions such as learning and memory. Fascinating new research led by Professor Akiyoshi Saitoh and Junpei Takahashi from the Tokyo University of Science has shed light on how oxytocin influences memory, opening new avenues for […]
Brain fog is one of the most common, persistent complaints in patients with long COVID. It affects as many as 46% of patients who also deal with other cognitive concerns like memory loss and difficulty concentrating. Now, researchers believe they know why. A new study has found that these symptoms may be the result of […]
The long-term impact of traumatic brain injury (TBI) on neurologic and psychiatric function is well-established, but a growing body of research is pointing to unexpected medical sequalae, including cardiovascular disease (CVD). A recent review looked at the investigation to date into this surprising connection, not only summarizing study findings but also suggesting potential mechanisms that […]
Lecanemab (Leqembi®) is an antibody intravenous (IV) infusion therapy that targets and removes beta-amyloid from the brain. It has received traditional approval from the U.S. Food and Drug Administration (FDA) to treat early Alzheimer’s disease, including people living with mild cognitive impairment (MCI) or mild dementia due to Alzheimer’s disease who have confirmation of elevated […]
Jan 29 (Reuters) – The first human patient has received an implant from brain-chip startup Neuralink on Sunday and is recovering well, the company’s billionaire founder Elon Musk said.”Initial results show promising neuron spike detection,” Musk said in a post on the social media platform X on Monday.Spikes are activity by neurons, which the National […]
ST. LOUIS — Joe knew something was terribly wrong when his wife, an energetic nurse and mother of three, becameforgetful in her early 60s. Four years ago, Lynn was diagnosed with dementia but decided against having a spinal tapthat would have shown whether the cause was Alzheimer’s disease. The couple chose to pursue a lifelong […]
The largest study to date of chronic traumatic encephalopathy(CTE) in young athletes shows that 41% had the neurodegenerative disease, caused by repetitive head impacts (RHIs). Analysis of brain tissue from athletes who were exposed to RHIs and died before the age of 30 revealed neuropathological evidence of shrinkage of the brain and microscopic changes that […]
Welcome to Impact Factor, your weekly dose of commentary on a new medical study. I’m Dr F. Perry Wilson of the Yale School of Medicine. If you happen to be watching this on a Sunday, Monday, or Thursday and live in the United States, there’s a good chance you’re watching NFL football tonight. Twenty million […]
